EXPERIMENTAL INVITRO ENDOTHELIALIZATION OF CARDIAC-VALVE LEAFLETS

被引:33
作者
EBERL, T
SIEDLER, S
SCHUMACHER, B
ZILLA, P
SCHLAUDRAFF, K
FASOL, R
机构
[1] UNIV FREIBURG, DEPT CARDIOVASC SURG, HUGSTETTERSTR 55, W-7800 FREIBURG, GERMANY
[2] UNIV VIENNA, DEPT SURG 2, A-1010 VIENNA, AUSTRIA
[3] UNIV CAPE TOWN, DEPT CARDIOTHORAC SURG, CAPE TOWN, SOUTH AFRICA
基金
奥地利科学基金会;
关键词
D O I
10.1016/0003-4975(92)90275-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study reports our results with in vitro endothelialization of fresh nonpreserved homograft valve leaflets compared with mild alternatively preserved valves and valves treated by preservation procedures commonly used for commercially available tissue valves. In vitro lining of biological heart valves with cultured autologous endothelial cells might help prevent the detrimental effects of degeneration on valve durability. To investigate the growth characteristics of endothelial cells on valve bioprostheses, three different methods of storage and preservation were compared. After precoating with fibronectin and seeding of 4.4 x 10(4) endothelial cells/cm2 onto the different leaflet surfaces, primary adherence, growth kinetics, morphology, and maintenance of monolayer integrity were studied over a period of 10 days. On valve leaflet surfaces of group 1 (fresh nonpreserved homograft valve leaflets) and group 2 (mild alternatively preserved valves), endothelial cells grew to persistent monolayers between days 6 and 10. In contrast, endothelial cell proliferation with monolayer growth could not be achieved on the group 3 leaflets (preserved like commercially available biological valve prostheses). In that group, no viable endothelial cells could be found on the valve surfaces 2 days after seeding. These results demonstrate the theoretical feasibility of endothelializing biological heart valve leaflets in vitro if they are not preserved and stored according to commonly used procedures. Provided such an endothelium can withstand the mechanical forces after implantation in vivo, in vitro endothelialization might contribute either to the development of new biological heart valves for modern cardiac surgery or to the improvement of clinical results with homograft valve transplants.
引用
收藏
页码:487 / 492
页数:6
相关论文
共 29 条
[1]  
BORTOLOTTI U, 1985, J THORAC CARDIOV SUR, V90, P564
[2]  
DEWANJEE MK, 1986, T AM SOC ART INT ORG, V32, P24
[3]   BINDING OF SOLUBLE FORM OF FIBROBLAST SURFACE PROTEIN, FIBRONECTIN, TO COLLAGEN [J].
ENGVALL, E ;
RUOSLAHTI, E .
INTERNATIONAL JOURNAL OF CANCER, 1977, 20 (01) :1-5
[4]  
Fasol R, 1985, Trans Am Soc Artif Intern Organs, V31, P276
[5]  
FERRANS VJ, 1978, CIRCULATION, V58, P10
[6]   PATHOLOGY OF ANTIBIOTIC-TREATED HUMAN HEART VALVE ALLOGRAFTS [J].
GAVIN, JB ;
HERDSON, PB ;
MONRO, JL ;
BARRATTB.BG .
THORAX, 1973, 28 (04) :473-481
[7]   PATHOLOGY OF CHEMICALLY-STERILIZED HUMAN HEART VALVE ALLOGRAFTS [J].
GAVIN, JB ;
BARRATTB.BG ;
HERDSON, PB .
PATHOLOGY, 1972, 4 (03) :175-&
[8]   HISTOPATHOLOGY OF FRESH HUMAN AORTIC-VALVE ALLOGRAFTS [J].
GAVIN, JB ;
BARRATTB.BG ;
HITCHCOCK, GC ;
HERDSON, PB .
THORAX, 1973, 28 (04) :482-487
[9]   TOXIC REACTIONS EVOKED BY GLUTARALDEHYDE-FIXED PERICARDIUM AND CARDIAC-VALVE TISSUE BIOPROSTHESIS [J].
GENDLER, E ;
GENDLER, S ;
NIMNI, ME .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1984, 18 (07) :727-736
[10]  
GEROULANOS S, 1979, HELV CHIR ACTA, V46, P91